UK invests £20M in AI-powered human models to improve drug testing
The UK Medical Research Council has announced a £20 million investment in a new pre-clinical translational models hub that will combine organoids, stem cell-derived systems, bioengineering, and artificial intelligence. Led by the Cambridge Stem Cell Institute, the initiative aims to create AI-driven human-based models that better reflect disease biology, with the goal of improving the safety and effectiveness of future medicines.
About LOG Standards
LOG Standards provides an independent accreditation signal for AI models used in healthcare, helping hospitals, care networks, and AI companies bring clinical AI readiness and governance into clearer conversations.
Our AI Intelligence Briefing tracks the latest developments in AI safety, AI in medicine, mental health AI, clinical AI governance, and regulatory policy — keeping healthcare stakeholders informed about the rapidly evolving AI landscape.